Related to this topic: Leaflets | Patient+ | UK Guidelines | News | Weblinks | Poem/Story | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Campylobacter Enteritis

This disease is a notifiable form of gastroenteritis in the UK under the Public Health (Infectious Diseases) Regulations 1988.
The Public Health Laboratory must be informed.

Campylobacteriosis is an infectious disease caused by bacteria of the genus Campylobacter and is the commonest reported bacterial cause of infectious intestinal disease in England and Wales.

18 species and subspecies exist, 11 of which are considered pathogenic to humans, causing enteric and extraintestinal illnesses. Two species are responsible for most campylobacter infections; C. jejuni and C. coli. They both produce a similar illness. Infection is very common and results in both enteric and systemic illness.

Pathogenesis
  • The source of infection is often undercooked meat, especially poultry. Studies have estimated 50% chicken carcasses are contaminated with campylobacter. It can also arise from unpasteurised milk and untreated water. It may arise from birds like blue tits pecking milk on doorsteps or from pets with diarrhoea.1 The source of infection in the majority of cases remains elusive.
  • The infective dose is relatively low for some people (<500) and the organism does not multiply in food. Outbreaks from food are rare. Large outbreaks are usually from raw and inadequately pasteurised milk and contaminated water supplies.2 Occupational exposure when processing poultry in abattoirs may cause some cases.
  • Incidence is highest in children followed by young adults.
  • There may be person to person transmission (faeco-oral route) with poor personal hygiene. Outbreaks occasionally occur in nurseries and institutions (attack rate 15-20%)3
  • Duration of shedding is 0-3 weeks, average 15 days. Untreated duration is 4 weeks. There is limited information on period of infectiousness, but patients probably not infectious if treated and diarrhoea has resolved.
  • For work or school the exclusion period should be 24 hours from last episode of diarrhoea,4 although a longer period of exclusion may be appropriate for children under 5 years and for older children who are unable to maintain good personal hygiene e.g. 48 hours.5
Epidemiology

According to the Health Protection Agency the number of faecal isolates of campylobacter rose from just under 25,000 in England and Wales in 1986 to a peak of over 57,000 in 2000, falling to around 46,603 in 2006.6 It is impossible to state if the rise in trend was a true rise in incidence or greater use of the laboratory service.

Risk factors

  • Undercooked meat, especially poultry
  • Birds pecking milk on doorsteps
  • Pets with diarrhoea
  • Raw and inadequately pasteurised milk
  • Contaminated water supplies
  • Occupational exposure when processing poultry in abattoirs
  • Traveller's diarrhoea in south east Asia, especially Thailand
Presentation

History

  • The incubation period can be from 1 to 11 days but is usually 2 to 5 days
  • There is a prodromal illness of fever, headache and myalgia lasting up to 24 hours. The fever may be as high as 40ºC and fever, whether high or low, may persist for a week.
  • There are abdominal pains and cramps and profuse diarrhoea with up to 10 stools a day. The stool is watery and often bloody.
  • There may be localised tenderness
  • Around a quarter of suffers have tenesmus

Examination

  • The patient often looks ill.
  • Temperature may be high or low, but pyrexia is present in over 90%.
  • The abdomen is diffusely tender, but tenderness may be more localised as right iliac fossa pain or left iliac fossa pain.
Investigations
  • A sample of faeces is sent for culture to isolate the organism. A single negative sample does not exclude the disease. Cultures are rarely positive after 2 weeks.
  • Microscopy of faeces may show erythrocytes and leukocytes.
  • U&E and creatinine may show evidence of dehydration.
  • Proctoscopy or sigmoidoscopy often shows proctocolitis, but it is difficult to distinguish from pseudomembranous colitis or ulcerative colitis.
Differential diagnosis
  • Bloody diarrhoea is usually suggestive of E. coli O157.
  • Right iliac fossa pain may mimic appendicitis.
  • Campylobacter produces abdominal pain rather more than Salmonella spp. or Shigella spp.
Management

Public Health should be notified of the case.
Avoid antimotility drugs as they prolong the illness and have even been associated with fatality. The basis of management is rehydration.

Rehydration

This can usually be achieved by the oral route, but in more severe cases intravenous fluids may be needed.

Antibiotics

The role of antibiotics is controversial.7,8 Some studies show that erythromycin rapidly eliminates campylobacter from the stool, but does not affect the duration of illness. Studies in children with dysentery due to C. jejuni have shown benefit from early treatment with erythromycin. Campylobacter acquired from animals may show multiple resistance to antibiotics because of the use of antibiotics in animals.9 However, rising numbers of ciprofloxacin resistant cases prompted withdrawal of quinolone use from commercial poultry farming recently in the USA.10

Antibiotics may be indicated if any of the following occur:

  • High fever
  • Bloody diarrhoea
  • More than 8 stools daily
  • Worsening clinical condition
  • Ill for over a week
  • Pregnancy
  • Immunocompromise

Erythromycin and azithromycin are the most potent agents against campylobacter, erythromycin displays the highest susceptibility (91.1%).Tetracyclines and quinolones should be avoided in children.
Lactobacilli and probiotics may have a place in the prevention and treatment of campylobacter and other forms of gastroenteritis but more research is needed.11,12

Complications
  • Acute bacterial gastroenteritis has been linked with the onset of irritable bowel syndrome (IBS) symptoms in approximately 15% of patients.13 These cases have been called postinfectious IBS. Campylobacter is commonly associated with postinfectious IBS as is E. coli, Salmonella spp.and Shigella spp.
  • Unusual complications include haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.
  • Other rare complications include Guillain Barré syndrome and reactive arthritis in the form of Reiter's syndrome.
  • Toxic megacolon is a rare, but serious complication.
Prognosis

The disease is usually self limiting. Occasionally death may occur from dehydration in the elderly and vulnerable, especially if immunocompromised. C.jejuni can produce a serious bacteraemic condition in AIDS.

Prevention
  • Milk should be pasteurised and drinking water chlorinated. It has been suggested that the provision of clean chlorinated water for chicken flocks might reduce the amount of contaminated meat reaching the market.
  • Meat must be adequately cooked.
  • Infected healthcare workers should not work. Antibiotic may reduce spread by curtailing the duration of excretion.
  • Cutting boards for cooked and uncooked meats and knives and other utensils must be kept apart. The prevention section of salmonella gastroenteritis is just as applicable to campylobacter.


Document references
  1. Blaser MJ, LaForce FM, Wilson NA, et al; Reservoirs for human campylobacteriosis. J Infect Dis. 1980 May;141(5):665-9. [abstract]
  2. Wood RC, MacDonald KL, Osterholm MT; Campylobacter enteritis outbreaks associated with drinking raw milk during youth activities. A 10-year review of outbreaks in the United States. JAMA. 1992 Dec 9;268(22):3228-30. [abstract]
  3. Cowden J; Campylobacter: epidemiological paradoxes. BMJ. 1992 Jul 18;305(6846):132-3.
  4. No authors listed; The prevention of human transmission of gastrointestinal infections, infestations, and bacterial intoxications. A guide for public health physicians and environmental health officers in England and Wales. A working party of the PHLS Salmonella Committee. Commun Dis Rep CDR Rev. 1995 Oct 13;5(11):R157-72.
  5. HPA - Campylobacter
  6. HPA - Laboratory reports of faecal isolates reported to the Health Protection Agency Centre for Infections England & Wales. Health Protection Agency, 1986-2006.
  7. Phavichitr N, Catto-Smith A; Acute gastroenteritis in children : what role for antibacterials? Paediatr Drugs. 2003;5(5):279-90. [abstract]
  8. Streit JM, Jones RN, Toleman MA, et al; Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003). Int J Antimicrob Agents. 2006 May;27(5):367-75. [abstract]
  9. Shea KM; Nontherapeutic use of antimicrobial agents in animal agriculture: implications for pediatrics. Pediatrics. 2004 Sep;114(3):862-8. [abstract]
  10. Nelson JM, Chiller TM, Powers JH, et al; Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story. Clin Infect Dis. 2007 Apr 1;44(7):977-80. Epub 2007 Feb 14. [abstract]
  11. Fernandez MF, Boris S, Barbes C; Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J Appl Microbiol. 2003;94(3):449-55. [abstract]
  12. Hutt P, Shchepetova J, Loivukene K, et al; Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J Appl Microbiol. 2006 Jun;100(6):1324-32. [abstract]
  13. Smith JL, Bayles D; Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis. J Food Prot. 2007 Jul;70(7):1762-9. [abstract]

Internet and further reading Acknowledgements EMIS is grateful to Dr Hayley Willacy for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2008.
DocID: 1900
Document Version: 23
DocRef: bgp349
Last Updated: 25 Apr 2008
Review Date: 25 Apr 2010


















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site








Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page